Mammography equipment enables early breast cancer detection through digital radiography, 3D tomosynthesis, and AI-enhanced imaging, saving lives via timely intervention. The global mammography equipment market size was worth USD 1.6 billion in 2024, and it is projected to grow from USD 1.72 billion in 2025 to USD 4.36 billion by 2033, growing at a CAGR of 10.12% during the forecast period (2025–2033).

Market Drivers

Rising breast cancer incidence globally accelerates screening program adoption, with 2.3 million new cases diagnosed annually requiring routine mammographic surveillance. Government mandates for national screening in women over 40 drive equipment procurement in public hospitals and diagnostic centers.

Technological advancements in digital breast tomosynthesis (DBT) and AI-powered detection improve diagnostic accuracy by 30-40% over 2D systems, reducing false positives and recall rates.

 

Get Your Sample Report Here: https://straitsresearch.com/report/mammography-equipment-market/request-sample

 

Market Challenges

High capital costs for DBT systems limit adoption in low-resource settings, with prices ranging from USD 150,000 to 300,000 per unit deterring small clinics. Reimbursement delays and budget constraints in public healthcare systems slow replacement cycles.

Radiologist shortages in emerging markets create bottlenecks despite equipment availability, requiring tele-radiology integration and AI triage solutions.

Market Segmentation

By Product Type

Digital mammography systems dominate with flat-panel detectors replacing film-screen technology for superior image quality and lower radiation doses. Digital breast tomosynthesis (3D mammography) grows fastest, capturing 45% share by 2033 as screening guidelines favor DBT for dense breasts.

Film-screen systems decline but persist in rural areas with limited infrastructure.

By Mobility

Stationary systems hold largest share installed in hospitals and dedicated breast imaging centers offering high-throughput screening. Portable units expand for mobile screening vans and remote outreach programs.

By End User

Hospitals command majority share with integrated radiology departments and surgical oncology units. Diagnostic imaging centers grow rapidly offering specialized breast care with shorter wait times.

Mobile screening centers serve underserved populations through government and NGO initiatives.

By Region

North America leads with advanced screening infrastructure and favorable reimbursement policies. Europe follows with mandatory national programs in UK, Germany, and Scandinavia. Asia Pacific exhibits highest growth fueled by rising awareness and healthcare investments in China and India.

Top 10 Competitors in the Mammography Equipment Market

  1. Hologic Inc. – Market leader with 35% global share, pioneering Selenia Dimensions 3D tomosynthesis and AI-powered Genius 3D Mammography.

  2. GE HealthCare Technologies Inc. – Offers Senographe Pristina with patient-friendly compression and AI-driven workflow optimization.

  3. Siemens Healthineers AG – Mammomat Revelation system features bio-prone positioning and ClearCE contrast-enhanced imaging.

  4. FUJIFILM Holdings Corporation – Amulet Innovality combines DBT with synthetic 2D and AI-based lesion detection.

  5. Canon Medical Systems Corporation – Alphenix platform integrates mammography with interventional breast biopsy capabilities.

  6. Koninklijke Philips N.V. – DigitalDiagnost C90 with AI-powered image reconstruction and dose reduction algorithms.

  7. Carestream Health Inc. – Cost-effective DRX-Revolution mobile systems for screening outreach in emerging markets.

  8. Planmed Oy – Finnish specialist in dedicated breast imaging with Nuance DM and Solace 3D systems.

  9. Konica Minolta Inc. – Regius Pure 190 digital systems serving Asian diagnostic centers with high reliability.

  10. IMS Giotto S.p.A. – Italian manufacturer offering Giotto Class DBT with ergonomic design and low-dose protocols.

These companies drive innovation through AI integration, contrast-enhanced mammography, and patient-centric ergonomics.

About Us

Straits Research is a market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision-makers. Straits Research Pvt. Ltd. provides actionable market research data, especially designed and presented for decision making and ROI.